Amneal Pharmaceuticals resubmitted a new drug application for its migraine treatment to the Food and Drug Administration, ... such as Ozempic and Rybelsus. The company's GLP-1 agonist, called ...

Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life improvements occurring despite minimal weight changes.

Hope may be on the horizon, however, according to a new pilot study published on June 17 in Headache: The Journal of Head and Face Pain. This discovery may lead to a novel treatment approach that ...

Researchers say liraglutide, a GLP-1RA, might help migraine by reducing intracranial pressure, but it's too soon to say whether it will become a migraine treatment. Ozempic-Like Drug Liraglutide ...

Migraines are one of the world's most common neurological conditions, impacting nearly 15% of people globally. Despite this widespread impact, many sufferers find current preventive treatments ...

Ozempic-like drugs used to treat type 2 diabetes and obesity may also treat migraine, ... If confirmed, however, the findings could open up a new line of inquiry for migraine treatment, ...

That Ozempic Headache Is Real — Here’s How To Beat It. Posted on May 13, 2025 - By Shannon Dawson. ...

Medications such as Ozempic and Saxenda have grown in popularity due to their ability to treat type 2 diabetes and assist in ...

A current weight-loss and diabetes drug has become a surprise candidate for migraine treatment, with a new pilot study showing the GLP-1 receptor agonist provided significant relief to sufferers ...

New research finds that men taking a GLP-1 for their obesity or type 2 diabetes often experience a rise in testosterone levels.

Some 20 weeks after stopping their drugs, the participants in the studies had put back on an average of 2.5 kilograms (5.5 ...

* Researchers at the Danish Headache Center are testing semaglutide along with a very low calorie diet as a treatment for new ...